Edesa Biotech EDSA Cash Flow Statement (2013-2026)

NASDAQ EDSA
$2.85 +0.03 (+1.06%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Edesa Biotech Quarterly Cash Flow Statement

Periods 48 quarters
Latest Jun 2026

Edesa Biotech cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 48 quarters of results from Aug 2013 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Aug2013 Dec2013 Aug2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-4.76M23.00M-4.38M-4.57M-5.79M32.28M-2.33M-2.33M-1.98M-1.75M-1.68M-1.86M-1.67M-0.99M-1.62M-1.59M-1.75M-2.24M-2.25M-5.41M
Depreciation and DepletionDep. & Depletion
2,481.00M1,909.00M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.08M0.05M0.05M0.05M0.05M0.04M0.04M0.02M0.03M0.03M0.03M
Share-based CompensationStock Comp.
1.10M0.90M0.61M0.63M0.57M0.46M0.33M0.29M0.11M0.52M0.18M0.15M0.10M0.09M0.08M0.07M0.20M0.40M0.40M0.50M
Gains from Equity InvestmentsGains Equity
Gains from Sales and DivestituresGains Divest
Gains from Investment SecuritiesGains Investment
Other non-cash itemsOther Non-Cash
-1.00
Change in Working Capital
Change in ReceivablesChange Receivables
-3.56M-0.78M0.43M-2.50M0.17M-0.13M1.06M-2.20M-0.01M0.59M0.10M0.38M-0.56M-0.28M0.10M0.03M-0.11M0.36M-0.22M
Change in InventoryChange Inventory
Change in Accured ExpensesChange Accured Exp.
-3.59M0.51M0.29M1.57M2.46M-3.44M-0.94M0.29M-0.22M0.31M0.10M0.21M0.22M-0.52M0.03M-0.89M-0.26M0.40M-0.33M
Change in Other Operating AssetsOther Assets Change
-0.54M-1.11M-0.19M0.09M0.13M-0.01M0.06M-0.20M-0.20M0.04M-0.04M-0.20M0.13M-0.09M-0.04M-0.03M0.00M-0.03M0.16M
Change in Other Operating LiabilitiesOther Liabilities Change
Other Working Capital ChangesOther WC Changes
0.54M1.11M0.19M-0.09M-0.13M0.01M-0.06M0.20M0.20M-0.04M0.04M0.20M-0.13M0.09M0.04M0.03M0.00M0.03M-0.16M
Cash from OperationsCash from Ops.
-3.12M-0.36M-3.21M-0.42M-3.03M-5.63M-1.79M-1.57M-1.81M-1.47M-1.41M-1.66M-0.86M-0.98M-1.52M-2.38M-1.70M-1.72M-2.10M
Investing Activities
Capital ExpendituresCapex
0.00M0.00M0.00M0.00M0.00M-41.00
Sales of Property, Plant and EquipmentPP&E (Sale)
Change in Property, Plant and EquipmentChange in PP&E
0.00M0.00M0.00M0.00M0.00M41.00
Change in IntangiblesChange Intangibless
Acquisitions
Net of Acquisitions & DivestmentsNet Acquisitions
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Cash from Investing ActivitiesCash from Investing
0.00M0.00M0.00M0.00M0.00M41.00
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Non-Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
Change in Capital Stock
Common Stock IssuedStock Issued
0.02M0.06M1.29M10.67M120.003.03M0.77M0.83M0.48M0.32M0.28M0.14M0.63M6.87M0.22M3.50M
Net Shares Issued and RepurchasedNet Shares Issued
0.02M0.06M1.29M10.67M120.003.03M0.77M0.83M0.48M0.32M0.28M0.14M0.63M6.87M0.22M3.50M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
1.54M
Net Equity Issued and RepurchasedNet Equity Issued
0.02M0.06M1.29M10.67M120.003.03M0.77M0.83M0.48M0.32M0.28M0.14M2.17M6.87M0.22M3.50M
Other financing activitiesOther financing
0.16M-0.06M-0.27M-406.00-0.12M-0.01M-0.09M-0.07M-0.01M0.01M-0.10M0.07M-0.14M
Cash from Financing ActivitiesCash from Financing
0.02M0.22M1.23M10.40M-286.002.91M0.76M0.74M0.41M0.31M0.21M0.11M-0.03M2.07M14.77M0.19M3.36M
Additional items
Exchange Rate EffectFX Effect
0.19M-0.08M0.02M0.02M-0.05M-0.09M0.06M0.01M0.05M-0.04M0.01M-0.02M-0.01M-0.01M-0.03M-0.06M0.17M-0.04M-0.01M
Change in Cash
-2.91M-0.21M-1.96M10.01M-3.08M-5.72M1.18M-0.80M-1.01M-1.10M-1.09M-1.47M-0.76M-1.00M0.53M12.33M-1.53M-1.57M1.26M
Ending Cash Balance
7.84M5.88M15.89M12.81M7.09M8.27M7.47M6.46M5.36M4.27M2.80M2.04M1.04M1.56M13.90M12.36M10.79M12.05M10.33M
Free Cash FlowFCF
-3.12M-0.35M-3.21M-0.42M-3.03M-5.63M-1.79M-1.57M-1.81M-1.47M-1.41M-1.66M-0.86M-0.98M-1.52M-2.38M-1.70M-1.72M-2.10M
Net Cash FlowNCF
-3.11M-0.13M-1.98M9.98M-3.03M-5.63M1.12M-0.81M-1.06M-1.06M-1.10M-1.45M-0.75M-1.01M0.55M12.39M-1.70M-1.53M1.26M
Income Taxes PaidTaxes Paid

Edesa Biotech Cash Flow Statement API

Pull Edesa Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EDSA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY